This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 May;17(5):391-392.

doi: 10.1016/S1474-4422(18)30122-4.

Understanding risk of PML through multiple sclerosis

Roland Martin¹

Affiliations

Affiliation

¹ Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University Zurich, 8091 Zurich, Switzerland. Electronic address: roland.martin@usz.ch.

PMID: 29656736
DOI: 10.1016/S1474-4422(18)30122-4

Free article

Comment

Understanding risk of PML through multiple sclerosis

Roland Martin. Lancet Neurol. 2018 May.

Free article

. 2018 May;17(5):391-392.

doi: 10.1016/S1474-4422(18)30122-4.

Author

Roland Martin¹

Affiliation

¹ Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University Zurich, 8091 Zurich, Switzerland. Electronic address: roland.martin@usz.ch.

PMID: 29656736
DOI: 10.1016/S1474-4422(18)30122-4

No abstract available

PubMed Disclaimer

Comment on

Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned.
Major EO, Yousry TA, Clifford DB. Major EO, et al. Lancet Neurol. 2018 May;17(5):467-480. doi: 10.1016/S1474-4422(18)30040-1. Lancet Neurol. 2018. PMID: 29656742 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information